Prilosec and Febuxostat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prilosec (omeprazole) and Febuxostat (febuxostat). Common drug interactions include thrombosis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Prilosec and Febuxostat. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Prilosec?

Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,285 Prilosec users. Check the latest studies of Prilosec.

What is Febuxostat?

Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 9,693 Febuxostat users. Check the latest studies of Febuxostat.



On Jul, 26, 2026

51 people who take Prilosec and Febuxostat together, and have interactions are studied.

Prilosec and Febuxostat drug interactions.

What are the common drug interactions of Prilosec and Febuxostat, by gender? *:

female:

  1. Thrombosis (formation of a blood clot inside a blood vessel)
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Fatigue (feeling of tiredness)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Blood pressure increased
  8. Headache (pain in head)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Nephropathy (damage to or disease of a kidney)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Cardiac failure chronic
  4. Fall
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Loss of consciousness
  7. Skin cancer
  8. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  9. Nephropathy (damage to or disease of a kidney)
  10. Abdominal pain upper

What are the common drug interactions of Prilosec and Febuxostat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephropathy (damage to or disease of a kidney)

40-49:

  1. Chronic kidney disease

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Fall
  4. Loss of consciousness
  5. Nephritis (inflammation of the nephrons in the kidneys)
  6. Skin cancer
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  8. Abdominal pain upper
  9. Adrenal disorder
  10. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Bursa disorder
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Type 2 diabetes mellitus
  6. Anaemia (lack of blood)
  7. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  8. Arrhythmia (irregular heartbeat)
  9. Cardiac failure chronic
  10. Cardiac failure congestive

What are the existing conditions these people have? *

  1. Pain: 17 people, 33.33%
  2. High Blood Pressure: 16 people, 31.37%
  3. High Blood Cholesterol: 11 people, 21.57%
  4. Gout (uric acid crystals building up in the body): 10 people, 19.61%
  5. Diabetes: 7 people, 13.73%
  6. Hypersensitivity: 6 people, 11.76%
  7. Immunodeficiency Common Variable: 6 people, 11.76%
  8. Inflammation: 6 people, 11.76%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 11.76%
  10. Blood Pressure Abnormal: 6 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Prilosec and Febuxostat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prilosec and Febuxostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prilosec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Febuxostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prilosec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Febuxostat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole and febuxostat (the active ingredients of Prilosec and Febuxostat, respectively), and Prilosec and Febuxostat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: